Sign inJoin waitlistJoin the waitlist

DT

Debasish Tripathy

Hematology & Oncology

Credentials: · · · ·

History

Hematology and Medical Oncology
1988–1991
Internal Medicine
1985–1988
Duke University School of Medicine
1981–1985

Research

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after…
Journal of Clinical Oncology · 1999 · 2,255 citations
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
Journal of Clinical Oncology · 1996 · 1,163 citations
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing…
Journal of Clinical Oncology · 1998 · 903 citations

Vicente Valero
15 papers
Gabriel Hortobagyi
14 papers
Laura Esserman
14 papers
Kathy Albain
13 papers
Lajos Pusztai
12 papers
Angela DeMichele
10 papers
Hope Rugo
10 papers
Naoto Ueno
10 papers
Carlos Barcenas
9 papers
DH
Daniel Hayes
9 papers
Funda Meric-Bernstam
9 papers
Jo Chien
9 papers

Grants

Mechanism-Based Evaluations of ErbB-Targeted Agents
National Cancer Institute · U54
Project lead · $633.1K · University of California, San Francisco
2002
SPORE in Breast Cancer
National Cancer Institute · P50
Project lead · $1.6M · University of California, San Francisco
1997–2002

Clinical trials

Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer
Principal investigator · Completed · Phase 1, Phase 2
M.D. Anderson Cancer Center
2018–2024